Search
Aurora Cannabis Inc
ACBAdd to Watchlist
2.930USD
+0.010+0.34%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
172.72MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Aurora Cannabis Inc is 7.20, ranking 107 out of 157 in the Pharmaceuticals industry. The average price target is 32.00, with a high of 32.00 and a low of 32.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
32.000
Target Price
+443.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Aurora Cannabis Inc
ACB
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Aurora Cannabis Inc's expected revenue for the next quarter?
Aurora Cannabis Inc's expected revenue is 49.28M.
What is Aurora Cannabis Inc's price target?
Analysts forecast that Aurora Cannabis Inc's price target is USD 32.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 32.00.
How have Aurora Cannabis IncACB's recent earnings per share performed?
The market expectation was USD -0.71, while Aurora Cannabis IncACB's earnings per share (EPS) for the previous quarter was USD 0.02. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Aurora Cannabis Inc?
Based on the ratings of Aurora Cannabis Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
